Poly Medicure Limited has informed the Exchange about Allotment of 33,775 Equity Shares to Eligible Employees under ESOS Scheme, 2020.
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Poly Medicure's board, at a meeting on 24th September 2025, approved the acquisition of 100% stake in the Citieffe Group (Medistream SA, Switzerland, and its subsidiaries in Italy, USA, and Mexico) through its wholly owned subsidiary Poly Medicure B.V., Amsterdam. The Citieffe Group will become step-down subsidiaries of Poly Medicure. Additionally, the board allotted 33,775 equity shares of Rs. 5 face value at an exercise price of Rs. 100 per share to eligible employees under the ESOS Scheme 2020. As a result, the paid-up equity capital rose from Rs. 50.66 crore to Rs. 50.68 crore, with total shares now at 10,13,59,490.
The acquisition expands Poly Medicure's international footprint in the medical devices space, potentially boosting future revenues, though deal value and funding details were not disclosed. The small ESOP allotment is a routine event with negligible dilution impact on existing shareholders.